Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Cell|July 15, 2016
Antagonizing Self-Renewal in Acute Myeloid Leukemia: ID2 Takes the StageGauri Deb, Tim C P Somervaille
Data in Brief|March 16, 2016
Data in support of the negative influence of divalent cations on (-)-epigallocatechin-3-gallate (EGCG)-mediated inhibition of matrix metalloproteinase-2 (MMP-2)Gauri Deb, Sahil Batra, Anil M Limaye
Epigenetics|May 7, 2013
Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyondGauri Deb, Vijay S Thakur, Sanjay Gupta
Molecular Cancer Research : MCR|February 15, 2014
EZH2: not EZHY (easy) to dealGauri Deb, Anup Kumar Singh, Sanjay Gupta
American Journal of Physiology. Cell Physiology|July 25, 2022
Matrix proteoglycans in tumor inflammation and immunityGauri Deb, Alexander Cicala, Athanasios Papadas, et al.
Indian Journal of Experimental Biology|April 30, 2014
Epigallocatechin gallate induces the steady state mRNA levels of pS2 and PR genes in MCF-7 breast cancer cellsC Mohan C Manjegowda, Gauri Deb, Anil M Limaye
Molecular Carcinogenesis|February 1, 2014
Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cellsGauri Deb, Vijay S Thakur, Anil M Limaye, et al.
The AAPS Journal|December 6, 2013
Plant phytochemicals as epigenetic modulators: role in cancer chemopreventionVijay S Thakur, Gauri Deb, Melissa A Babcook, et al.
Genomics Data|October 21, 2015
Expression profiling of genes modulated by estrogen, EGCG or both in MCF-7 breast cancer cellsMohan C Manjegowda, Gauri Deb, Neeraj Kumar, et al.
Molecular Carcinogenesis|March 12, 2019
Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymesGauri Deb, Eswar Shankar, Vijay S Thakur, et al.
Pageof 2